Role of lysosomes in silica-induced inflammasome activation and inflammation in absence of MARCO

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Biswas, Rupa ^a   Hamilton, Raymond F ^a   Holian, Andrij ^a  

^a UNIVERSITY OF MONTANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; PROTEIN MARCO; SCAVENGER RECEPTOR; SILICON DIOXIDE; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG; CARRIER PROTEIN; CHOLESTEROL; CIAS1 PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; MARCO PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PERMEABILIZATION; CELL VIABILITY; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; INFLAMMATION; LIPID METABOLISM; LUNG ALVEOLUS MACROPHAGE; LYSOSOME; LYSOSOME MEMBRANE; MALE; MOUSE; NONHUMAN; PHAGOLYSOSOME; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION; GENETICS; INTRACELLULAR SPACE; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; CARRIER PROTEINS; CASPASE 1; CATHEPSIN B; CHOLESTEROL; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; INFLAMMASOMES; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTRACELLULAR SPACE; LYSOSOMES; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, IMMUNOLOGIC; SILICON DIOXIDE; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 84904175340     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/304180     Document Type: Article

References (42)

1. World Health Organization, The Global Occupational Health Network (GOHNET). GOHNET Newsletter 2007 12
2. Hamilton R. F. Jr., Thakur S. A., Holian A., Silica binding and toxicity in alveolar macrophages. Free Radical Biology and Medicine 2008 44 7 1246 1258 10.1016/j.freeradbiomed.2007.12.027 2-s2.0-40949129640
3. Sankala M., Brännström A., Schulthess T., Bergmann U., Morgunova E., Engel J., Tryggvason K., Pikkarainen T., Characterization of recombinant soluble macrophage scavenger receptor MARCO. The Journal of Biological Chemistry 2002 277 36 33378 33385 10.1074/jbc.M204494200 2-s2.0-0037031903 (Pubitemid 34984861)
4. Arredouani M. S., Yang Z., Imrich A., Ning Y., Qin G., Kobzik L., The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles. American Journal of Respiratory Cell and Molecular Biology 2006 35 4 474 478 10.1165/rcmb.2006-0128OC 2-s2.0-33749169359 (Pubitemid 44477647)
5. Hamilton R. F. Jr., Thakur S. A., Mayfair J. K., Holian A., MARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice. The Journal of Biological Chemistry 2006 281 45 34218 34226 10.1074/jbc. M605229200 2-s2.0-33845945947 (Pubitemid 46036630)
6. Józefowski S., Arredouani M., Sulahian T., Kobzik L., Disparate regulation and function of the class A scavenger receptors SR-AI/II and MARCO. The Journal of Immunology 2005 175 12 8032 8041 10.4049/jimmunol.175.12.8032 2-s2.0-29144533040 (Pubitemid 41798365)
7. Areschoug T., Gordon S., Scavenger receptors: role in innate immunity and microbial pathogenesis. Cellular Microbiology 2009 11 8 1160 1169 10.1111/j.1462-5822.2009.01326.x 2-s2.0-67650102353
8. Takeuchi O., Akira S., Pattern recognition receptors and inflammation. Cell 2010 140 6 805 820 10.1016/j.cell.2010.01.022 2-s2.0-77950343791
9. Palecanda A., Paulauskis J., Al-Mutairi E., Imrich A., Qin G., Suzuki H., Kodama T., Tryggvason K., Koziel H., Kobzik L., Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles. The Journal of Experimental Medicine 1999 189 9 1497 1506 10.1084/jem.189.9.1497 2-s2.0-0033519286 (Pubitemid 29227536)
10. Palecanda A., Kobzik L., Receptors for unopsonized particles: the role of alveolar macrophage scavenger receptors. Current Molecular Medicine 2001 1 5 589 595 10.2174/1566524013363384 2-s2.0-0035523086 (Pubitemid 33772037)
11. Thakur S. A., Hamilton R. Jr., Pikkarainen T., Holian A., Differential binding of inorganic particles to MARCO. Toxicological Sciences 2009 107 1 238 246 10.1093/toxsci/kfn210 2-s2.0-58049191414
12. Baqir M., Chen C.-Z., Martin R. J., Thaikoottathil J., Case S. R., Minor M. N., Bowler R., Chu H. W., Cigarette smoke decreases MARCO expression in macrophages: implication in Mycoplasma pneumoniae infection. Respiratory Medicine 2008 102 11 1604 1610 10.1016/j.rmed.2008.05.002 2-s2.0-55549083140
13. Arredouani M. S., Palecanda A., Koziel H., Huang Y., Imrich A., Sulahian T. H., Ning Y. Y., Yang Z., Pikkarainen T., Sankala M., Vargas S. O., Takeya M., Tryggvason K., Kobzik L., MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. The Journal of Immunology 2005 175 9 6058 6064 10.4049/jimmunol.175.9.6058 2-s2.0-27144471020 (Pubitemid 41508092)
14. Thakur S. A., Beamer C. A., Migliaccio C. T., Holian A., Critical role of MARCO in crystalline silica-induced pulmonary inflammation. Toxicological Sciences 2009 108 2 462 471 10.1093/toxsci/kfp011 2-s2.0-64349101066
15. Moretti J., Blander J. M., Insights into phagocytosis-coupled activation of pattern recognition receptors and inflammasomes. Current Opinion in Immunology 2014 26 100 110 10.1016/j.coi.2013.11.003
16. Johansson A. C., Appelqvist H., Nilsson C., Kågedal K., Roberg K., Öllinger K., Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis 2010 15 5 527 540 10.1007/s10495-009-0452-5 2-s2.0-77951666702
17. Eskelinen E. L., Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Molecular Aspects of Medicine 2006 27 5-6 495 502 10.1016/j.mam.2006.08.005 2-s2.0-33749041268 (Pubitemid 44466656)
18. Luzio J. P., Pryor P. R., Bright N. A., Lysosomes: fusion and function. Nature Reviews Molecular Cell Biology 2007 8 8 622 632 10.1038/nrm2217 2-s2.0-34547134198 (Pubitemid 47106614)
19. Boya P., Kroemer G., Lysosomal membrane permeabilization in cell death. Oncogene 2008 27 50 6434 6451 10.1038/onc.2008.310 2-s2.0-54949137644
20. Guicciardi M. E., Leist M., Gores G. J., Lysosomes in cell death. Oncogene 2004 23 16 2881 2890 10.1038/sj.onc.1207512 2-s2.0-2442476459 (Pubitemid 38638850)
21. Gasse P., Riteau N., Charron S., Girre S., Fick L., Pétrilli V., Tschopp J., Lagente V., Quesniaux V. F. J., Ryffel B., Couillin I., Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. American Journal of Respiratory and Critical Care Medicine 2009 179 10 903 913 10.1164/rccm.200808-1274OC 2-s2.0-65649140025
22. Pedra J. H., Cassel S. L., Sutterwala F. S., Sensing pathogens and danger signals by the inflammasome. Current Opinion in Immunology 2009 21 1 10 16 10.1016/j.coi.2009.01.006 2-s2.0-64049096349
23. Drenth J. P., van der Meer J. W., The inflammasome-a linebacker of innate defense. The New England Journal of Medicine 2006 355 7 730 732 10.1056/NEJMcibr063500 2-s2.0-33747340486
24. Franchi L., Eigenbrod T., Muñoz-Planillo R., Nuñez G., The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nature Immunology 2009 10 3 241 247 10.1038/ni.1703 2-s2.0-60749104683
25. Dinarello C. A., Immunological and inflammatory functions of the interleukin-1 family. Annual Review of Immunology 2009 27 519 550 10.1146/annurev.immunol.021908.132612 2-s2.0-62649139025
26. Hoffman H. M., Wanderer A. A., Inflammasome and IL-1 β -mediated disorders. Current Allergy and Asthma Reports 2010 10 4 229 235 10.1007/s11882-010-0109-z 2-s2.0-77956394358
27. Biswas R., Bunderson-Schelvan M., Holian A., Potential role of the inflammasome-derived inflammatory cytokines in pulmonary fibrosis. Pulmonary Medicine 2011 2011 8 105707 10.1155/2011/105707 2-s2.0-84857845432
28. Hornung V., Bauernfeind F., Halle A., Samstad E. O., Kono H., Rock K. L., Fitzgerald K. A., Latz E., Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nature Immunology 2008 9 8 847 856 10.1038/ni.1631 2-s2.0-47849097202
29. Cassel S. L., Eisenbarth S. C., Iyer S. S., Sadler J. J., Colegio O. R., Tephly L. A., Carter A. B., Rothman P. B., Flavell R. A., Sutterwala F. S., The Nalp3 inflammasome is essential for the development of silicosis. Proceedings of the National Academy of Sciences of the United States of America 2008 105 26 9035 9040 10.1073/pnas.0803933105 2-s2.0-47849132947
30. Davis C. N., Mann E., Behrens M. M., Gaidarova S., Rebek M., Rebek J. Jr., Bartfai T., MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics. Proceedings of the National Academy of Sciences of the United States of America 2006 103 8 2953 2958 10.1073/pnas.0510802103 2-s2.0-33644523710
31. Canals D., Perry D. M., Jenkins R. W., Hannun Y. A., Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases. British Journal of Pharmacology 2011 163 4 694 712 10.1111/j.1476-5381.2011.01279.x 2-s2.0-79958052481
32. Johansson A. C., Appelqvist H., Nilsson C., Kagedal K., Roberg K., Ollinger K., Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis 2010 15 5 527 540 10.1007/s10495-009-0452-5 2-s2.0-77951666702
33. Deng D., Jiang N., Hao S. J., Sun H., Zhang G. J., Loss of membrane cholesterol influences lysosomal permeability to potassium ions and protons. Biochimica et Biophysica Acta: Biomembranes 2009 1788 2 470 476 10.1016/j.bbamem.2008.11.018 2-s2.0-59249089696
34. Hao S. J., Hou J. F., Jiang N., Zhang G. J., Loss of membrane cholesterol affects lysosomal osmotic stability. General Physiology and Biophysics 2008 27 4 278 283 2-s2.0-60149087399
35. Reiners J. J. Jr., Kleinman M., Kessel D., Mathieu P. A., Caruso J. A., Nonesterified cholesterol content of lysosomes modulates susceptibility to oxidant-induced permeabilization. Free Radical Biology and Medicine 2011 50 2 281 294 10.1016/j.freeradbiomed.2010.11.006 2-s2.0-78651232046
36. Hentze H., Lin X. Y., Choi M. S. K., Porter A. G., Critical role for cathepsin B in mediating caspase-1-dependent interleukin-18 maturation and caspase-1-independent necrosis triggered by the microbial toxin nigericin. Cell Death and Differentiation 2003 10 9 956 968 10.1038/sj.cdd.4401264 2-s2.0-0042914359 (Pubitemid 37069473)
37. Hampton R. Y., Golenbock D. T., Penman M., Krieger M., Raetz C. R. H., Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 1991 352 6333 342 344 10.1038/352342a0 2-s2.0-0025874032 (Pubitemid 21912355)
38. Chen Y., Wermeling F., Sundqvist J., Jonsson A., Tryggvason K., Pikkarainen T., Karlsson M. C. I., A regulatory role for macrophage class A scavenger receptors in TLR4-mediated LPS responses. European Journal of Immunology 2010 40 5 1451 1460 10.1002/eji.200939891 2-s2.0-77951710075
39. Migliaccio C. T., Buford M. C., Jessop F., Holian A., The IL-4R pathway in macrophages and its potential role in silica-induced pulmonary fibrosis. Journal of Leukocyte Biology 2008 83 3 630 639 10.1189/jlb.0807533 2-s2.0-43349091452 (Pubitemid 351966873)
40. Huanq Y. L., Huang W. P., Lee H., Roles of sphingosine 1-phosphate on tumorigenesis. World Journal of Biological Chemistry 2011 2 2 25 34 10.4331/wjbc.v2.i2.25
41. von Bismarck P., Wistädt C. F., Klemm K., Winoto-Morbach S., Uhlig U., Schütze S., Adam D., Lachmann B., Uhlig S., Krause M. F., Improved pulmonary function by acid sphingomyelinase inhibition in a newborn piglet lavage model. American Journal of Respiratory and Critical Care Medicine 2008 177 11 1233 1241 10.1164/rccm.200705-752OC 2-s2.0-44449165512 (Pubitemid 351860932)
42. Poh M. K., Shui G., Xie X., Shi P. Y., Wenk M. R., Gu F., U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. Antiviral Research 2012 93 1 191 198 10.1016/j.antiviral.2011.11. 014 2-s2.0-84355162292